Literature DB >> 2065046

Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V.

R E Maser1, S K Wolfson, D Ellis, E A Stein, A L Drash, D J Becker, J S Dorman, T J Orchard.   

Abstract

Cardiovascular disease is a frequent complication of insulin-dependent diabetes mellitus (IDDM), but the prevalence, interrelations, and risk factors of its principal components (coronary, cerebrovascular, and lower-extremity arterial disease) and of medial arterial wall calcification are not well understood. To address these issues, data from the Epidemiology of Diabetes Complications Study (n = 657) baseline examination were examined. The term coronary heart disease (CHD) was applied to those with myocardial infarction or angina, whereas lower-extremity arterial disease (LEAD) was applied to those who had undergone amputation of a lower limb or who had an ankle to arm blood pressure ratio less than 0.8 at rest or after exercise. Calcification of the lower-extremity arteries was considered to be present if ankle pressure was more than 100 mm Hg higher than brachial pressure. Although the prevalence of CHD was low, LEAD was significantly more common in women than in men (p less than 0.01), whereas calcification was more frequent in men than in women (p less than 0.01). Ten percent of those with LEAD also had CHD, and 8% with LEAD had calcification. Modeling of potential risk factors (e.g., diabetes duration and glycosylated hemoglobin) revealed that duration, female gender, fibrinogen, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and high density lipoprotein cholesterol to apolipoprotein A-I ratio were independent predictors of LEAD, whereas for CHD only, diabetes duration and hypertension contributed to CHD. Calcification revealed a mixed pattern, with duration, hypertension, and triglyceride to apolipoprotein A-I ratio being the statistically significant associated factors. The results suggest that although LEAD, CHD, and calcification often coexist, their risk factor profiles differ.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065046     DOI: 10.1161/01.atv.11.4.958

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  26 in total

Review 1.  Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.

Authors:  John N Stabley; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-22       Impact factor: 8.311

Review 2.  Vascular disease in the lower limb in type 1 diabetes.

Authors:  Michael Edmonds
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

3.  Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

Authors: 
Journal:  Diabetes       Date:  1999-02       Impact factor: 9.461

Review 4.  Diabetic dyslipidaemia: current treatment recommendations.

Authors:  J D Best; D N O'Neal
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

5.  Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2010-09-15       Impact factor: 5.162

6.  Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia.

Authors:  Yvonne M Searls; Rajprasad Loganathan; Irina V Smirnova; Lisa Stehno-Bittel
Journal:  Cardiovasc Diabetol       Date:  2010-02-01       Impact factor: 9.951

7.  Hemorheological disorders in diabetes mellitus.

Authors:  Young I Cho; Michael P Mooney; Daniel J Cho
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Lower limb arterial incompressibility and obstruction in rheumatoid arthritis.

Authors:  I del Rincón; R W Haas; S Pogosian; A Escalante
Journal:  Ann Rheum Dis       Date:  2004-07-22       Impact factor: 19.103

9.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

Review 10.  Type 1 diabetes.

Authors:  Mark A Atkinson; George S Eisenbarth; Aaron W Michels
Journal:  Lancet       Date:  2013-07-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.